First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG

Sören Reinhard, Jochen Sven Utikal, Anne Zaremba, Georg Lodde, Imke von Wasielewski, Kai Christian Klespe, Friedegund Meier, Sebastian Haferkamp, Katharina C. Kähler, Rudolf Herbst, Christoffer Gebhardt, Anca Sindrilaru, Edgar Dippel, Yenny Angela, Peter Mohr, Claudia Pfoehler, Andrea Forschner, Martin Kaatz, Beatrice Schell, Anja Gesierich, Carmen Loquai, Jessica C. Hassel, Jens Ulrich, Frank Meiss, Gaston Schley, Lucie M. Heinzerling, Michael Sachse, Julia Welzel, Carsten Weishaupt, Cord Sunderkötter, Christiane Michl, Harm-Henning Lindhof, Alexander Kreuter, Markus V. Heppt, Saskia Wenk, Cornelia Mauch, Carola Berking, Annekathrin Silvia Nedwed, Ralf Gutzmer, Ulrike Leiter, Dirk Schadendorf, Selma Ugurel, Michael Weichenthal, Maximilian Haist, Maria Isabel Fleischer, Berenice Lang, Stephan Grabbe, Henner Stege

Open source

DOI: 10.1016/j.ejca.2025.115356
Published: 2025-05
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2025.115356,
  title = {First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG},
  author = {Sören Reinhard and Jochen Sven Utikal and Anne Zaremba and Georg Lodde and Imke von Wasielewski and Kai Christian Klespe and Friedegund Meier and Sebastian Haferkamp and Katharina C. Kähler and Rudolf Herbst and Christoffer Gebhardt and Anca Sindrilaru and Edgar Dippel and Yenny Angela and Peter Mohr and Claudia Pfoehler and Andrea Forschner and Martin Kaatz and Beatrice Schell and Anja Gesierich and Carmen Loquai and Jessica C. Hassel and Jens Ulrich and Frank Meiss and Gaston Schley and Lucie M. Heinzerling and Michael Sachse and Julia Welzel and Carsten Weishaupt and Cord Sunderkötter and Christiane Michl and Harm-Henning Lindhof and Alexander Kreuter and Markus V. Heppt and Saskia Wenk and Cornelia Mauch and Carola Berking and Annekathrin Silvia Nedwed and Ralf Gutzmer and Ulrike Leiter and Dirk Schadendorf and Selma Ugurel and Michael Weichenthal and Maximilian Haist and Maria Isabel Fleischer and Berenice Lang and Stephan Grabbe and Henner Stege},
  year = {2025},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2025.115356},
  url = {https://doi.org/10.1016/j.ejca.2025.115356}
}

RIS

TY  - JOUR
TI  - First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG
AU  - Sören Reinhard
AU  - Jochen Sven Utikal
AU  - Anne Zaremba
AU  - Georg Lodde
AU  - Imke von Wasielewski
AU  - Kai Christian Klespe
AU  - Friedegund Meier
AU  - Sebastian Haferkamp
AU  - Katharina C. Kähler
AU  - Rudolf Herbst
AU  - Christoffer Gebhardt
AU  - Anca Sindrilaru
AU  - Edgar Dippel
AU  - Yenny Angela
AU  - Peter Mohr
AU  - Claudia Pfoehler
AU  - Andrea Forschner
AU  - Martin Kaatz
AU  - Beatrice Schell
AU  - Anja Gesierich
AU  - Carmen Loquai
AU  - Jessica C. Hassel
AU  - Jens Ulrich
AU  - Frank Meiss
AU  - Gaston Schley
AU  - Lucie M. Heinzerling
AU  - Michael Sachse
AU  - Julia Welzel
AU  - Carsten Weishaupt
AU  - Cord Sunderkötter
AU  - Christiane Michl
AU  - Harm-Henning Lindhof
AU  - Alexander Kreuter
AU  - Markus V. Heppt
AU  - Saskia Wenk
AU  - Cornelia Mauch
AU  - Carola Berking
AU  - Annekathrin Silvia Nedwed
AU  - Ralf Gutzmer
AU  - Ulrike Leiter
AU  - Dirk Schadendorf
AU  - Selma Ugurel
AU  - Michael Weichenthal
AU  - Maximilian Haist
AU  - Maria Isabel Fleischer
AU  - Berenice Lang
AU  - Stephan Grabbe
AU  - Henner Stege
PY  - 2025
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2025.115356
UR  - https://doi.org/10.1016/j.ejca.2025.115356
ER  -

APA

Reinhard, S., Utikal, J. S., Zaremba, A., Lodde, G., Wasielewski, I. V., Klespe, K. C., Meier, F., Haferkamp, S., Kähler, K. C., Herbst, R., Gebhardt, C., Sindrilaru, A., Dippel, E., Angela, Y., Mohr, P., Pfoehler, C., Forschner, A., Kaatz, M., Schell, B., Gesierich, A., Loquai, C., Hassel, J. C., Ulrich, J., Meiss, F., Schley, G., Heinzerling, L. M., Sachse, M., Welzel, J., Weishaupt, C., Sunderkötter, C., Michl, C., Lindhof, H., Kreuter, A., Heppt, M. V., Wenk, S., Mauch, C., Berking, C., Nedwed, A. S., Gutzmer, R., Leiter, U., Schadendorf, D., Ugurel, S., Weichenthal, M., Haist, M., Fleischer, M. I., Lang, B., Grabbe, S., & Stege, H. (2025). First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115356

Source records

crossref · retrieved 2026-09-26T19:30:39.550Z